Insights from daratumumab use in highly sensitized pediatric heart transplant candidates and recipients: A single-center institutional experience and outcomes

By afschroeder • August 19, 2025

Husain M, Butler C, Fan AM, Halnon NJ, Reardon LC, Alejos JC. Insights from daratumumab use in highly sensitized pediatric heart transplant candidates and recipients: A single-center institutional experience and outcomes. JHLT Open. 2025 Jul 17;10:100346. doi: 10.1016/j.jhlto.2025.100346. PMID: 40822087; PMCID: PMC12354783.

Tags: allosensitization, Cardiology/Epi, complex congenital heart disease, daratumumab, desensitization, Pediatric heart transplant, Publications

Improving Heart Failure Quality of Care Over the First Twenty Years: The Get With the Guidelines-Heart Failure Program

Tang AB, Li S, Li Y, Zhao J, Thomas K, Lewsey SC, Heidenreich PA, Greene SJ, Allen LA, Jessup M, Bolles M, Rutan C, Navar[...]

Pericoronary fat attenuation and its association with atherosclerosis in rheumatoid arthritis compared with controls: a cross-sectional study

Karpouzas GA, Cosedis Enevoldsen F, Rezaeian P, Masic D, Budoff MJ, Hauge EM, Ormseth SR. Pericoronary fat attenuation and its association with atherosclerosis in rheumatoid[...]

Transpulmonary eicosanoid metabolite gradients: insights into metabolic flux of pro- and anti-inflammatory metabolites and lung function

Mounsey LA, Alotaibi M, Parekh JK, Nemeth SM, McNeill JN, Cheng S, Jain M, Lewis GD, Ho JE. Transpulmonary eicosanoid metabolite gradients: insights into metabolic[...]